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BB rats spontaneously develop insulin-dependent, ketosis-prone diabetes mel- 
litus (DM)) Their disease is of autoimmune etiology, since it is characterized by: 
(a) lymphocytic and rnacrophage inflammation of pancreatic islets (1), (b) circu- 
lating autoantibodies that bind to pancreatic islets of Langerhans (2), (c) increased 
incidence of Ia antigen-bearing T  lymphocytes associated with the development 
of diabetes  (3),  (d)  progressive  and  selective  destruction  of insulin-producing 
beta ceils (1,  4),  (e)  the ability to transfer disease to  immunodeficient animals 
with concanavalin A-activated splenic lymphocytes (5), and (f) selective destruc- 
tion of beta cells in transplanted islets (6); in addition, it can be prevented with 
many  forms  of immunotherapy  (7).  BB  rats  also  exhibit  a  profound  T  cell 
lymphocytopenia with an almost total lack of circulating T  lymphocytes, although 
their  thymocytes are  normal  in  number  and  cell  surface  phenotype  (8).  In 
breeding  studies,  we  and  others  (9,  10)  have  shown  that  at  least  two  genes 
contribute  to  the  development  of diabetes  in  the  BB  rat.  One  is  autosomal 
recessive  and  determines  the  profound  T  cell  immunodeficiency present  in 
affected rats at birth. The second is linked to RTI, the rat major histocompati- 
bility complex (MHC). 
To further define the BB rat's RTl-linked diabetogenic gene, we asked whether 
there are MHC differences between BB rats and control strains at the genomic 
level  (as  determined  by  studying  restriction  fragment  length  polymorphism 
[RFLP])  that are  related  to  MHC diabetogenicity, as determined  in  breeding 
studies.  Using  a  class  II  H-2  A-alpha  probe,  we previously reported  (11)  the 
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existence of four polymorphic MHC types in the control BBN population, which 
reflects the colony from which the BB rat was derived, only one of which was 
found in BB rats. We also reported preliminary results (12) using class I, II, and 
III MHC probes to find polymorphisms that further subdivide the BB and BBN 
population. In this paper we extend those preliminary findings and characterize 
five  RFLP-defined  MHC  types  in  the  BBN  population  and  a  distinct  RFLP- 
defined  MHC  type  present  only in  BB rats,  using  a  class  I  MHC  probe.  We 
evaluated the diabetogenicity of these RFLP-defined MHC  chromosome types 
in a  breeding study and determined the serologic RT! phenotypes encoded by 
these  chromosomes  using  monoclonal  antibodies.  These  findings  allow  us  to 
provide preliminary localization of the MHC-linked diabetogenic gene of rats as 
well as insight into the organization of class  II genes in the RT1 complex. The 
organization of these studies is schematized in Fig.  1. 
Materials and Methods 
Animals.  BB/O rats and Wistar control rats (here termed BBN) were kindly provided 
by Dr. Pierre Thibert (Department of National Health and Welfare, Ottawa, Canada) or 
bred from his stock in the animal facility at the Joslin Diabetes Center. BB/W rats from 
sublines with a  high incidence of diabetes (NC, PA, FA, BF) or low incidence sublines 
(WA, WC) were provided by Dr. A. A. Like (University of Massachusetts Medical Center, 
Worcester, MA).  Animals from a  new strain of diabetic rats (BB-Hooded) with a  95% 
incidence of diabetes, developed by Dr. J. Logothetopoulos (Best and Banting Institute, 
Toronto, Canada),  were also provided by Dr. Thibert.  BB/O and BBN rats were co- 
derived from the same original outbred colony by selection for (BB/O) or against (BBN) 
the development of diabetes. Both strains are maintained as outbred closed colonies. BB/ 
W  rats have been inbred by brother-sister mating for  16+ generations. Low-incidence 
BB/W sublines were split off from the high incidence BB/W lines after six generations of 
inbreeding by selecting against the development of diabetes, and are often referred to as 
W-line rats. BBN and W-line rats do not exhibit the T  cell immunodeficiency present in 
the diabetes-prone BB/O, BB/W (high incidence sublines), and BB-Hooded rats. Wistar 
Furth (WF) Buffalo, Lewis, and ACI rats were obtained from Harlan Sprague Dawley, 
Inc. (Indianapolis, IN). Animals were housed according to NIH guidelines at the animal 
facility at the Joslin Diabetes Center and provided ad libitum commercial rat chow and 
water.  Diabetes-prone  animals  were  screened  every  2-3  d  for  glycosuria  and  were 
determined to be diabetic if they had serum glucose values >300 mg/dl on two consecutive 
days. Diabetic animals were maintained with daily doses of Lente insulin (Eli Lilly & Co., 
Indianapolis, IN). 
Probes.  The  A-alpha  probe  was  isolated by  Dr.  A.  Ben-Nun  (Weitzman  Institute, 
Rehovot, Israel) and is a  1.3  kb  HindIII genomic fragment of the  A-alpha  region of 
C57BL/10 encoding part  of the alpha  1 and  all  of the  alpha  2,  transmembrane and 
intracytoplasmic domains as well as intervening introns. The DC-beta probe was provided 
by Dr. P. Peterson (University of Uppsala, Uppsala, Sweden) and is a cDNA clone of a 
HLA-DC-Iike gene (13).  The E-beta probe (subclone 8.48,  kindly provided by Dr.  L. 
Hood, California Institute of Technology, Pasadena, CA) is a 7.2 kb genomic fragment 
encoding the beta-1  and beta-2 domains of E  d (14). The E-alpha probe used is a  1.4 kb 
BglII genomic fragment of a  Pstl subclone of cosId-alpha-1  (kindly provided by Dr. R. 
Flavell, Biogen, Cambridge, M A) encoding the alpha-1 domain of E  d (15). Three class I II 
genomic probes were used: probe f as well as a  6.7 kb BamHI fragment and a  2.5 kb 
BamHI fragment of cosmid E7 from the "sex-limited protein" area of H-2 (16,  17). The 
class I  probe (S16) is a  500 basepair genomic fragment of the third coding block (C-2 
domain)  of H-2L  d (18).  Because  of high  sequence  homology in  MHC  genes  among 
mammals, it is assumed though not proved that these probes hybridize with genes in rats 
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DNA  Isolation  and  Determination  of RFLP.  ~1  cm  of rat  tail  was  frozen  in  liquid 
nitrogen and stored at -80°C until  use.  The tail  was cut into 1-2-ram slices, placed on 
ice  in  2 ml 0.1  M  NaCl,  0.2  M sucrose,  0.01  M EDTA,  0.03  M Tris-HC1,  pH  8,  and 
homogenized using a Polytron (Brinkman Instruments Co., Westbury, NY). Then, 0.5 ml 
of 0.25 M EDTA, 2.5% sodium dodecyl sulfate (SDS), 0.5 M Tris-HCI, pH 9.2 was added 
and the mixture incubated at 65°C for 30 min. 0.3 ml 8 M potassium acetate was added, 
the mixture incubated for 1 h on ice, and the aqueous solution was extracted twice with 
5 ml  100:1  chloroform/isoamyl alcohol. DNA was precipitated from the aqueous phase 
with a final concentration of 50% ethanol for 10 rain at room temperature. The methods 
for RFLP analysis have been previously described (11) except as noted below.  For class I 
RFLP analysis,  25  ug of DNA were  digested  to  completion using restriction  enzyme 
EcoRI (New England BioLabs, Beverly, MA) in appropriate buffer. DNA fragments were 
separated on 0.7% agarose gels, transferred to nitrocellulose filters,  and hybridized with 
3zP-labeled DNA probe. All hybridizations were done at high stringency, with final washes 
at 50°C in 30 mM NaCI, 3 mM trisodium citrate, and 0.1% SDS. Autoradiography was 
used to visualize bands of specifically bound, labeled probe. 
Determination  of T  Cell Lymphopenia.  A  rapid  screening assay  for lymphopenia had 
been  developed  and  found  (9)  to  be  both  sensitive  and  specific  compared  with  our 
standard assay. Briefly,  0.125 ml of blood was collected into heparinized Natelson tubes 
and mixed with 0.125 ml RPMI 1640 plus 4 mg/ml gentamycin sulfate (RPMI plus G) in 
96-well V-bottomed plates.  The plates were centrifuged at  1,000 g and the supernatants 
were aspirated.  The anti-rat  T  cell  monoclonal antibody OX19 (Accurate Chemical & 
Scientific  Corp., Westbury, NY) was diluted  1:100 with RPMI plus G and 0.5% bovine 
serum albumin; 0.05 ml was added to each well, incubated for 45 min at 4°C, and washed 
twice with 0.2 ml RPMI plus G. A second incubation, with 0.05 ml fluorescein-conjugated 
F(ab')2  goat anti-mouse IgG (diluted  1:10 in  rat serum;  Tago, Inc., Burlingame, CA), 
was for 45 rain at 4°C. The cells were washed three times with RPMI plus G. The red 
cell/white  cell  pellet  was diluted  10-fold with  phosphate-buffered saline,  and  105 cells 
were  evaluated  for  the  presence  of T  lymphocytes using an  Epics  V  flow cytometer 
(Coulter Electronics Inc., Hialeah, FL) as previously described (9). Typically, nonlympho- 
penic animals have a 5-10-fold higher percentage of OX 19-positive cells than do lympho- 
penic  animals  by  this  assay.  Known  lymphopenic and  nonlymphopenic animals  were 
included in each assay as positive and negative controls. 
RT1  Typing.  Class I  MHC typing (RT1.A) was determined by indirect immunofluo- 
rescence on  Ficoll-Hypaque-isolated peripheral  blood mononuclear cells  as  previously 
described (9) using monoclonal antibodies LWF.415 (anti-RT1.A  u) and AP. 1.1.13 (anti- 
RTI.Aa).  Class II MHC  typing (RTI.B and  RTI.D) was determined  on  Ficoll-Hypaque 
density gradient  (specific  gravity,  1.090)-purified splenic  mononuclear cells  as  follows. 
Surface immunoglobulin was capped in the presence of excess fluorescein-labeled rabbit 
anti-rat  IgG  (Cappel  Laboratories,  Cochranville,  PA),  diluted  1:25  in  RPMI  plus  G 
containing 20%  fetal  bovine serum,  for  1 h at  37°C.  Capped cells  were washed three 
times with phosphate-buffered saline  plus 0.1% sodium azide (PBS plus Az) to prevent 
further  capping.  A  second incubation  was  carried  out  in  the  presence  of monoclonal 
antibody supernatants specific  for RTI.B  u (LW2.3C9) or RT1.D a (4D11) for 1 h at 4°C. 
The splenocytes were again washed three times in PBS plus Az and then incubated with 
an excess of rhodaminated rabbit anti-rat IgG (Cappel  Laboratories) diluted 1:25 in PBS 
plus Az. Cells  were washed three times with  PBS  plus Az and examined with a  Leitz- 
Diavert microscope equipped for epifluorescence. A reaction was considered positive if 
>90% of cells exhibiting fluorescein capping (surface immunoglobulin-positive B cells) 
also exhibited  rhodamine rim  fluorescence (class II antigen).  WF (RFI"), AC1  (RTla), 
Lewis (RTI~), and Buffalo (RT1 b) rats were used as positive  or negative controls. These 
antibodies were either produced in Dr. E. Milford's laboratory (LWF.415, LW2.3C9, and 
4D11) or kindly provided by Dr. E. Blankenhorn (AP. 1.1.13)  (University of Pennsylvania 
Medical  School, Philadelphia,  PA). The method used for class II RT1  typing was kindly 
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Data  were  analyzed  using  a  CLINFO  computer  sytem  (NIH  GCRC  No.  5M01 
RR00888-10CLR. 
Results 
RFLP Analysis Using Class H MHC Probes.  We have previously reported (11) 
the existence of class  II  MIqC polymorphisms  in  the  BB (diabetes-prone) and 
BBN  (control  strain  "BB  normal")  population  using  an  A-alpha  probe.  To 
summarize,  in  the  rats  studied  using  restriction  enzyme  BamHI,  the  A-alpha 
(class  II)  probe  hybridizes  with  two  bands,  designated  "1"  and  "2".  Using 
restriction  enzyme  EcoRI,  the  A-alpha  probe  also hybridizes  with  two bands, 
designated "a" and "b". Thus, using the A-alpha probe with BamHI and EcoRI, 
four polymorphic patterns are seen, which we have defined as type la (BamHI 
2.9 kb, EcoRI 8.2 kb), type lb (BamHI 2.9 kb, EcoRI 1.7 kb), type 2a (BamHI 
2.4 kb, EcoRI 8.2 kb), and type 2b (BamHI 2.4 kb, EcoRI 1.7 kb). These RFLP 
patterns are inherited  in a  classic Mendelian fashion.  The results of our RFLP 
analysis using the A-alpha probe in BB, BBN, and Wistar Furth rats are presented 
in Table I. All diabetes-prone BB strain animals (BB/O, BB/W, and BB-Hooded 
rats In =  30]) are 2a/2a homozygotes. In the BBN population,  la,  lb, 2a, and 
2b chromosomes exist and most animals are heterozygotes (Table I). Analyzed 
in  terms of chromosomes, the population  of BBN rats  we studied consisted of 
48% 2a, 35%  lb, 16%  Ia, and  1% 2b chromosomes. (Since 2b rats are very rare 
and because we were unable to breed them, they have not been studied further.) 
Wistar  Furth  rats  (WF),  an  inbred  strain  of rat  bearing  the  RTL  u haplotype, 
share  A-alpha  RFLP type 2a-defined  homozygosity with BB rats.  We used  10 
other restriction enzymes (Apal, BglII, EcoRV, HindIII, Kpnl, Pstl, PvuII, Sacl, 
Smal,  Xhol)  to try to subdivide 2a rats  using the  A-alpha  probe, but,  with all 
enzymes, BB/O, BBN 2a, and WF rats showed identical banding patterns.  The 
same was true using enzyme Mspl for WF, BB/W, BB/O, and BB-Hooded rats. 
Other class II probes were used in an effort to further subdivide the BB and 
BBN  rat  population.  A  DC-beta  probe  with  restriction  enzymes  BamHI  and 
TABLE  I 
A-Alpha-defined RFLP Types in BB, BBN, and WF Rats 
Chromosome type  BBN (n)  BB* (n)  WF (n) 
2a/2a  30  30  3 
2b/2b  0  0  0 
la/la  2  0  0 
Ib/lb  t3  0  0 
2a/la  10  0  0 
2a/lb  22  0  0 
2a/2b  0  0  0 
la/lb  16  0  0 
1  b/2b  2  0  0 
lb/2a* or la/2b  32  0  0 
* BB  rats  included  18  BB/O  rats,  6  BB  hooded,  4  BB/W  from  high 
incidence litters, and 5 BB/W from low incidence litters. 
* These  heterozygous  types  cannot  be  distinguished  except  in  family 
studies. 22 of 22 of animals with this RFLP pattern are 1  b/2a according 
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CLASS ~  CLASS  I  BREEDING, 
RFLP  RFLP  STUDY 
BB 
(diobetes)  •  2o 
OUTBRED / 
WISTAR  /  20 
"~,  B.BN  tcomrol)  ~  to 
lb 
=  200  DIABETOGENIC 
/  2a2  DIA  BETOGENIC 
2a|  DIABETOGENIC 
,~  10  NON-DIABETOGENIC 
-  tb  NON-DIABETOGENIC 
FIGURE  l.  Schematization of our experiments to define diabetogenic MHC haplotypes in 
the BB and BBN rat populations. Both strains were derived from the same outbred Wistar rat 
colony by selecting for the development of diabetes (BB) or against the development of 
diabetes (BBN). Class II RFLP analysis subdivides the control BBN rats into four subgroups 
(la, lb, 2a, and 2b), while BB rats exhibit one of these (2a). (2b BBN rats are not included in 
this figure since they are rare and we have not been able to breed them.) Class I RFLP analysis 
absolutely distinguishes BB (2a0) from BBN rats (2al, 2a2, la,  lb). A breeding study was 
carried out to evaluate the diabetogenicity of the various RFLP-defined MHC haplotypes. 
EcoRI generated the same data  (though different band  molecular sizes) as did 
the A-alpha probe with restriction enzyme BamHI (distinguishing "1" BBN rats 
[la and  lb]  from  2a  rats  [BB/O,  WF,  and  2a  BBN]).  However, there  was  no 
polymorphism analogous to that seen with A-alpha and EcoRI (12). An E-alpha 
probe also generated the same pattern of polymorphisms (though, again, differ- 
ent molecular sizes), with restriction enzymes BamHI and EcoRI, distinguishing 
la  and  lb  rats  from  2a  rats  (BB/O,  WF,  and  BBN).  However, no  RFLP  was 
evident  with  enzyme  HindlII  and  PvuII  using  the  E-alpha  probe  (data  not 
shown).  An  E-beta probe showed no polymorphisms between  BB/O,  WF,  and 
la,  lb, and 2a BBNs using restriction enzymes BamHI and EcoRI. In addition, 
we were unable to subdivide 2a rats using the E-beta probe and the panel of 11 
restriction enzymes mentioned above for A-alpha (data not shown). 
To summarize (Fig.  1), the A-alpha class II probe, in concert with restriction 
enzymes BamHI and EcoRI, generates RFLPs that subdivide the BBN population 
into  la,  lb, 2a, and 2b rats. However, all BB rats exhibit the 2a A-alpha RFLP, 
as do all Wistar Furth rats. 
RFLP Analysis  Using Class III MHC Probes.  We  were  unable  to detect any 
polymorphisms between  BB/O,  WF,  and  la,  lb, and  2a BBN  rats  using three 
H-2 S-region probes from the area coding for the "sex-limited protein" (Slp) of 
H-2  with  restriction  enzymes BamHI,  EcoRI,  HindIII,  Mspl,  and  PvuII  (data 
not  shown).  These  probes  have  demonstrated  limited  polymorphisms  in  mice 
(16). 
RFLP Analysis Using Class I MHC Probes.  In contrast to other MHC probes, 
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FIGURE 2.  RFLP analysis using restriction enzyme EcoRI and the S16 class I probe in a lb 
BBN rat (lane I), la BBN (2), 2a2 BBN rat (3), 2al  BBN rat (4), BB-Hooded rat (5), BB/W 
W-line rat (6), and a Wistar Furth rat (7). All BB substrains as well as Wistar Furth rats 
exhibited the same class I RFLP (termed 2a0) and could be distinguished from all BBN rats. 
Markers at right designate molecular sizes in kilobases 23.7, 9.5, 6.7, 2.3, and 2.0, from top 
to bottom. 
rats.  At  least  five different patterns  were evident (Fig.  2) using the $16 probe 
and restriction enzyme EcoRI. BBN rats that exhibit the A-alpha  lb RFLP had 
a  distinctive band pattern  (Fig.  2,  lane  1) which we call class  I  RFLP  lb.  BBN 
rats  with  the  A-alpha  la  RFLP had another pattern  (Fig.  2,  lane  2)  which  we 
designate  la.  The A-alpha-defined  type 2a  RFLP can be divided into 2a!  and 
2a2  forms  using  the  S16  probe  in  concert with  EcoRI  (Fig.  2,  lanes  4  and  3, 
respectively). However, BB/O, BB/W (including high-incidence sublines and the 
control W  line),  BB-Hooded, and  Wistar  Furth  rats all  shared a  class  I  RFLP 
that we call  form  2a0  (2a because they exhibited the  2a  A-alpha  RFLP, and  0 
because they lacked bands in the 8.0-9.5  kb range where all other rats have at 
least one band). The 2a0 RFLP is shown in lanes 5 (BB-Hooded), 6 (BB/W low- 
incidence subline)  and  7  (WF)  of Fig.  2.  Similar distinguishing  polymorphisms 
are evident using restriction enzymes Xh01, PvuII, Smal, Pstl, Apal, Sacl, EcoRV, 
HindIII, BglII, and Kpnl. The 2al  RFLP (Fig. 2, lane 4) may have resulted from 
a crossover event between the  la class I RFLP (lane 2) and the 2a0 RFLP (lanes 
5-7), since it shares bands with both of these patterns. Table II gives a breakdown 
of S16 class I-defined EcoRI RFLPs in a  population of BB, WF, and BBN rats 
that also have the A-alpha-defined type 2a RFLP.  All BB and BB-derived rats 
(n =  37) have the 2a0 class I (S16)-defined RFLP (as do WF rats), while all BBN 
rats sharing the type 2a A-alpha  RFLP (n =  20) can be distinguished as having 
the  2al  or  2a2  class  I  RFLP,  distinct  from  the  2a0  rats.  In  contrast  to  our 
findings with the class II probes, where both BB and some BBN rats shared the 
2a A-alpha RFLP, the class I probe absolutely distinguished  BB rats (2a0) from 
BBN rats (2al, 2a2, class I  la and  lb) (Fig.  1). 450  DIABETOGENIC  HISTOCOMPATIBILITY HAPLOTYPES  IN  BB  RATS 
TABLE  II 
Class I MHC Probe (S16)-defined RFLP Types in BB, BBN (2a), and 
WF Rats 
Chromosome type  BBN (2a) (n)  BB* (n)  WF (n) 
2a0/2a0  0  36  8 
2al/2al  12  0  0 
2a2/2a2  I  0  0 
2al/2a2  7  0  0 
2a0/2al  0  0  0 
2a0/2a2  0  0  0 
* BB rats include 21  BB/O rats, 5 BB-Hooded rats, 4 BB/W rats from 
high incidence sublines, and 6 BB/W W-line rats. 
Breeding Study to Determine Diabetogenicity  of RFLP-defined Chromosomes.  BBN 
female rats with la, lb, and 2a A-alpha-defined RFLPs were mated with a single 
diabetic BB-Hooded male rat for a  study of the segregation of MHC polymor- 
phisms  with respect to the development of diabetes.  This strain  of diabetic rat 
was chosen because of its 95%  incidence of diabetes.  In the F~ animals derived 
from these  matings,  we determined  that  the class  I  and  II  MHC  RFLPs were 
inherited in a  Mendelian fashion, as expected. Namely, the offspring of a  la/la 
by 2a0/2a0  mating were all  la/2a0,  et cetera.  F~  rats were brother-sister mated 
to produce F2 rats. 
F2 rats were screened for lymphopenia when  25-35  d  old using monoclonal 
antibody  OX19,  as  described  in  Materials  and  Methods.  Overall,  131  of 557 
(23%) F2 rats were lymphopenic, not statistically different from the 25% expected 
inheritance of a recessive trait. The inheritance of lymphopenia was independent 
of the inheritance of MHC RFLPs. In lymphopenic F2 rats in which RFLPs were 
determined  (n  ---  131),  17%  were  homozygous for BBN-derived RFLPs,  56% 
were heterozygous for BB-H and BBN-derived RFLPs, and 27% were bomozy- 
gous for the BB-derived 2a0 RFLP (not statistically different from the expected 
1:2:1  normal  distribution  of a  recessive  trait).  In  nonlymphopenic F2  rats  in 
which RFLPs were determined (n =  96), the percent distribution was 22:55:23 
(again, not statistically different from that expected). 
To evaluate the diabetogenicity of the MHC RFLPs, we followed lymphopenic 
Fz animals  for the development of glycosuria and hyperglycemia (>300  mg/dl 
serum glucose). Of those that survived to 120 d  of age,  13 developed DM.  The 
breakdown of the incidence of diabetes as a  function of BBN grandparental  A- 
alpha-defined RFLP  type demonstrated  (Table III) a  significantly higher inci- 
dence of diabetes in lymphopenic F2 rats derived from 2a BBN matings than in 
those from  la  or  lb  BBN  matings,  suggesting a  diabetogenic effect of the  2a 
BBN MHC compared with the  la or lb BBN MHC. 
To further define the MHC association of diabetes, we studied the class I (S 16) 
RFLPs in lymphopenic Fz rats who survived to  120 d  of age.  The incidence of 
diabetes as a function of class I  RFLP types is presented in Table IV. There was 
no statistical difference in the incidence of diabetes among the various 2a subtypes 
defined by the class I probe. Among lymphopenic F2 rats that were homozygous 
for the  2a0  (BB derived) class  I  RFLP,  28%  (5  of 18) developed DM.  Among BUSE ET  AL. 
TABLE  III 
Incidence of Diabetes Among Lymphopenic F9 Rats as a Function of BBN 
Grandparental Class II (A-Alpha) RFLP Type 
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BBN Grand-  DM incidence 
parent A-alpha  n 
RFLP  No,  Percent 
la  20  1  5.0  X  ~  = 4.0, P < 0,05 
2a  29  8  27.6  X  2 = 4.5, P < 0,05  lb  45  4  8.9 
TABLE IV 
Class I (S16) RFLPs of Lymphopenic F2 Rats Surviving to 120 d of Age vs. Percent of Diabetes 
Mellitus 
Class 1 RFLP  n 
Incidence of DM 
No.  Percent 
BBMHC homozygotes 
BB/2a BBN MHC heterozygotes 
2a BBN MHChomozygotes 
BB/la or lb BBN MHC heterozygotes 
la or lb BBN MHC homozygotes 
2a0/2a0  18  5  27.8 
2a0/2al  8  3  37.5 
2a0/2a2  9  2  22.2 
17  5  29.4 
2al/2a2  3  2  66.7 
2a2/2a2  3  0  0 
6  2  33.3 
2a0/la  7  0  0 
2a0/lb  25  1  4.0 
32  1  3.1 
la/la  10  0  0 
lb/lb  11  0  0 
21  0  0 
lymphopenic 2a0/2al  and  2a0/2a2  rats  (heterozygotes for  BB[2a0]-and  BBN 
[2al  or  2a2]-derived MHC chromosomes), 29%  (5  of 17) developed DM.  And 
among lymphopenic  2al/2a2  or  2a2/2a2  rats  (homozygotes for  BBN-derived 
MHC chromosomes), 33%  (2 of 6) developed DM. These findings indicate that 
the diabetogenic effect of the BBN-derived 2al  and 2a2 MHC is similar to that 
of BB-derived 2a0 MHC. In contrast, of 21 lymphopenic F2 rats homozygous for 
the BBN-derived  la or  lb chromosome, none developed DM, indicating a  lack 
of diabetogenicity of the  la or lb MHC compared with the 2a MHCs (×2 =  7.6; 
P  <  0.01). 
Furthermore,  the  MHC-linked  diabetogenic  gene  seems  to  be  functionally 
recessive,  as  only  3%  (1  of  32)  lymphopenic  F~  rats  heterozygous  for  the 
nondiabetogenic  la  or  lb  MHC  and  the  BB-derived  2a0  MHC  developed 
diabetes, compared with 29%  (12 of 41) rats homo  zygous for either the BB- or 
BBN-derived diabetogenic 2a MHC RFLP (X  ~ =  8.4; P  <  0.005).  The one  lb/ 452  DIABETOGENIC  H1STOCOMPATIBILITY  HAPLOTYPES  IN  BB  RATS 
TABLE  V 
Serologic Typing of MHC RFLPs in BB and BBN Populations 
Class I  (S16)  Anti-  Anti-  Anti-  Anti- 
RFLP  RT1 .A  u  RT1 .A  a  RT1 .B"  RT1.D  a 
2a0/2a0  +  -  +  - 
2al/2al  +  -  +  - 
2a2/2a2  +  -  +  - 
la/la  -  +  -  + 
lb/lb  .... 
2a0  rat  that  developed diabetes  could  not  be  bred,  so  we  cannot  exclude  a 
recombination event in this animal. To summarize (see Fig. 1), the A-alpha class 
II  probe  allowed  us  to  distinguish  some  of the  control  BBN  rats  from  the 
diabetes-prone BB rats. The class I probe absolutely distinguished BB rats (2a0 
RFLP) from BBN rats (2al, 2a2,  la, and lb class I RFLPs), enabling us to follow 
the segregation of BB vs. BBN MHC chromosomes in matings of BB and BBN 
rats. The breeding study demonstrates that there is an MHC-linked diabetogenic 
gene associated with the 2a A-alpha RFLP in the BB (2a0) as well as the BBN 
(2al and 2a2) control rat populations, but not with the la or lb RFLP. 
Serologic  Determination  of RTl  Type  of RFLP-defined BBN MHC  Types.  Using 
indirect immunofluorescence with monoclonal antibodies directed against class 
I MHC antigens (RT1.A  a and RT1.A  u) and class II MHC antigens (RT1.B  u and 
RT1.Da),  we  determined the  serologic  RT1  type corresponding to  the  MHC 
RFLPs in the BB and BBN population (Table V).  Briefly, la/la rats expressed 
RT1 .A"D"; all 2a rats (2a0/2a0, 2al/2al, and 2a2/2a2) expressed RT1 .AUB  u but 
not RT1.Da; and RFLP  lb/lb rats did not express  RTI  a nor RTI" at the loci 
tested. 
Discussion 
The BB rat develops type I diabetes of autoimmune etiology. Previous studies 
have identified two genes as contributing to the development of diabetes. One 
determines the T  cell lymphopenia found in BB rats. The other is linked to RTI, 
the  MHC  of rats.  To  further define the  molecular basis  of the  diabetogenic 
MHC-linked gene of BB rats, we studied RFLP in BB and BBN rats. BBN rats 
are an outbred strain of rats maintained as a  closed colony in Ottawa, Canada 
and reflect the original commercial colony in which diabetes appeared and from 
which the various BB strains were developed. 
Using a class II A-alpha probe, we were able to distinguish four RFLP in the 
BBN population, only one of which (2a) has been found in three independently 
derived BB colonies. A  DC-beta probe  detected no additional polymorphisms 
that showed only linked polymorphisms homologous to the A-alpha RFLPs. An 
E-alpha probe also detected the same pattern of polymorphisms but only with 
two of four enzymes tested. Using an E-beta probe we were unable to detect any 
polymorphisms in the BBN or BB population. Mouse, human, and rat class  II 
MHC  genes  exhibit  considerable  sequence  homology (20)  and  these  probes 
should  recognize  RT1.B-alpha,  RT1.B-beta,  RT1.D-alpha,  and  RT1.D-beta 
sequences, respectively (19, 22).  Other investigators have detected limited poly- BUSE ET  AL.  453 
morphism  by  RFLP analysis  using  class  II  probes (23).  Our  findings  indicate 
otherwise, since four class II  RFLP were found in a  closed population  using a 
single  genomic  probe  (A-alpha)  and  two  restriction  enzymes.  The  degree  of 
RFLP among  class  II  gene  sequences  in  the  population  studied seems to  be: 
RT1.B-alpha  _  RT1.B-beta >  RT1.D-alpha  >__ RT1.D-beta.  In the H-2 system 
of mouse, the  class  II  region  has  been divided  into a  relatively conserved I-E 
subregion  and  a  more polymorphic  I-A  subregion.  E-beta  sequences span  the 
boundary of these two subregions and exhibit considerable RFLP, while E-alpha 
is  in  the  conserved  subregion  and  exhibits  little  RFLP  (24).  Therefore,  it  is 
surprising that in our rat population we could detect no polymorphisms using an 
E-beta probe; this suggests that the boundary between I suhregions of rats may 
be shifted such that the E-beta equivalent (RT l.D-beta) is in the more conserved 
I-E subregion. The E-beta gene of mouse is associated with a recombination "hot 
spot" that accounts for all intra-I  region recombinants (24).  It is interesting  to 
note that the only I region recombinant in rats has mapped between the A-beta 
and  A-alpha  equivalents  (23),  supporting  the  notion  that  intra-class  I!  region 
dynamics may be difficult in the rat than in the mouse. 
We were unable to find any polymorphisms using mouse class III MHC probes. 
A  class  I  probe (S16),  however,  identified  many polymorphisms  and  could be 
used to absolutely distinguish  BBN rats from  BB rats.  BBN rats  that  share  A- 
alpha-defined 2a RFLPs can be subdivided into 2al and 2a2 forms, while all BB 
rats and  BB-derived strains  have a  distinct  form that  we designated  2a0.  The 
S16 class I probe should hybridize with both  RT1.A and  RT1.C/E sequences, 
areas coding for both classical class I major histocompatibility antigens and Qa- 
and Tl-like molecules. As in the mouse, most class I genes have been mapped to 
the right  of the class II region, the RT1.C/E loci (23). These class I- and class 
II-defined RFLPs are inherited as tightly linked alleles (no evidence of recom- 
bination  using A-alpha  and  S16 probes in  123  F2 rats  derived from  la  or  lb 
BBN ×  2a0 BB matings [two meiotic events]). 
A breeding study was carried out to evaluate the diabetogenicity of the various 
MHC RFLP in the BB and  BBN population.  As expected, the BB-derived 2a0 
RFLP exerted a diabetogenic effect: 28% of 2a0 homozygous lymphopenic rats 
developed DM. Additionally, the 2al  and 2a2 BBN-derived RFLP are diabeto- 
genic while the  la and  lb BBN-derived RFLP are  nondiabetogenic.  Whether 
the diabetogenic gene in the BBN population is identical to that in BB rats is not 
known.  The age of onset of diabetes in  2a0/2a0  homozygous rats  (n =  5) was 
115.4 +  7.7 d  (mean +__ SEM); in 2a0/2al,  2a0/2a2, or 2al/2a2 diabetic rats (n 
=  7),  the age of onset was 88.4 +_ 8.0 d  (P <  0.05  by two-tailed t test).  These 
results suggest a form of synergism between the diabetogenic 2a0, 2al, and 2a2 
MHC-bearing chromosomes, analogous to the earlier age of onset of diabetes in 
patients with type I diabetes and having the HLA DR3/DR4 haplotype (Dr.  N. 
Maclaren,  personal  communication).  However, there was no analogous  higher 
incidence of DM in  2a heterozygotes compared with  2a0/2a0  lymphopenic  F2 
rats. 
The incidence of diabetes in lymphopenic F2 rats homozygous for diabetogenic 
MHC-bearing chromosomes  (type 2a0,  2al,  or  2a2)  is  ~10-fold  higher  (29%) 
than in lymphopenic F2 rats heterozygous for a nondiabetogenic halplotype (la 454  D1ABETOGEN1C  HISTOCOMPATIBILITY  HAPLOTYPES  IN  BB  RATS 
or lb) and the 2a0 diabetogenic haplotype (3%).  We do not know if the one lb/ 
2a0  rat  that  developed  diabetes  was  the  result  of a  crossover  between  the 
diabetogenic loci and the lb polymorphisms detected by RFLP analysis. In that 
case, the MHC-linked diabetogenic gene may be truly recessive. Alternatively, 
there may be a much lower incidence of diabetes among heterozygotes. In either 
case, the diabetogenic gene linked to the 2a  MHC RFLP neither functions in 
the classic  codominant fashion of MHC gene allele expression nor as a  classic 
immune response gene, which usually confers responsiveness to foreign antigens 
in a dominant fashion. In the NOD mouse, another animal model of spontaneous 
autoimmune type I DM, there is also an MHC-linked diabetogenic gene that acts 
in a recessive manner (26).  The same may be true of man since there is at least 
a fourfold increase in the incidence of overt diabetes in HLA identical siblings 
of patients with type I diabetes as compared with siblings having only one HLA 
haplotype in common with their diabetic sibling (27). 
The  "recessiveness"  of the  diabetogenic  influence  of MHC  genes  can  be 
explained by at least three mechanisms. If the MHC-linked diabetogenic gene is 
a class II immune response gene, a decreased incidence of diabetes in heterozy- 
gotes may be due to decreased cell surface expression of the diabetogenic class 
II  molecule on  antigen-presenting cells,  lymphocytes, or,  possibly,  the  target 
tissue. Class II molecules are expressed as alpha:beta heterodimers. In F1 animals 
(heterozygotes for MHC genes), it has been shown that the alpha and beta chains 
can associate randomly, resulting in one-half to one-eighth the level of expression 
of a parental type heterodimer compared with the parental strain (28);  further- 
more, the responsiveness of MHC-restricted T  cell clones as proportional to the 
concentration of responder class  II molecules (29).  Alternatively, the anti-islet 
immune response  involved in  type I  diabetes  may be  controlled by a  class  II 
immune "suppressor" gene. In such a system, low responsiveness is inherited as 
a dominant trait and high responsiveness as a recessive trait (30, 31).  Finally, the 
MHC-linked gene  involved  in  the  pathogenesis of type  I  DM  may code  for 
deletion of an enzyme. For example, congenital adrenal hyperplasia results from 
a deficiency in a 21-hydroxylase involved in cortisol biosynthesis and is inherited 
as an  MHC-linked autosomal recessive trait often associated with HLA-Bw47, 
C4A-null. Recent studies have defined the molecular basis of this disease associ- 
ation. The defect in 21-hydroxylation appears to be due to a deletion involving 
a  P-450  21-hydroxylase in the MHC. This deletion may have also deleted part 
of the neighboring HLA-B and C4A regions, converting the common HLA-B 13, 
C4A3 haplotype to the rare HLA-Bw47, C4A-null haplotype (32). 
Serologic typing of class I (RT1.A) and class II (RT1 .B and RT1.D) antigens 
in  BB  and  BBN  rats  showed  that  the  diabetogenic  2a0,  2al,  and  2a2  MHC 
RFLPs code for the expression of RT 1  .AUB  u while the nondiabetogenic la RFLP 
codes for RT1.AaD  ~ and the nondiabetogenic lb RFLP codes for neither RTI" 
nor RTI", at the loci tested. Others have reported that BB rats express serologi- 
cally defined RT1 .A  u antigens (6,  10) and that, among BBN rats, animals express 
RT1.A  a and/or RT1.A  u (33).  Examination of the class I ($16)  RFLPs in Fig.  1 
shows that 2al  RFLP (lane 4) may result from a crossover event between a  2a0 
(lanes 5-7) and a  la (lane 2) MHC-bearing chromosome. It is significant that the 
2al  RFLP codes for RT1.A°B  u and not D  a. Therefore, the hypothesized cross- BUSE  ET  AL.  455 
TABLE  VI 
Comparison of the Incidence of Diabetes Among Lymphopenic F2 Rats as a Function of 
Grandparental Control Strain and MHC Type 
Control strain:  L*  BN*  WF*  BBN  la  BBN  lb  BBN 2a 
RT1 type  1  n  u  a  Non-u  u 
n  88  237  63  20  45  29 
Percent DM  9.1  7.6  9.6  5.0  8.9  27.6* 
* L, BN, and WF refer to Lewis, Brown Norway, and Wistar Furth strains. Data for these rats were 
derived  from reference  8  by dividing n  by 4  to correct  for 25%  incidence of lymphopenia, and 
recalculating the percent DM. 
* Significantly different  from  WF  (X 2 =  5.0,  P  <  0.05).  All  other  differences from  WF  are  not 
statistically significant. 
over event that  may have "created"  the 2al  MHC-bearing chromosome would 
have occurred on the RT1.C side of RT1.D, and the diabetogenic MHC-linked 
gene would be on the class II side of the crossover. 
A  possible interpretation  of the results of the  breeding program  is that  the 
serologically defined  RT1 u contributes  to  the  development  of diabetes in  BB 
rats. However, data from our previous breeding study suggests otherwise (Table 
VI). In that  study, the incidence of diabetes in  F2  rats derived from WF x  BB 
crosses was similar to the incidence in Brown Norway ×  BB and Lewis x  BB F2 
rats as well as in F2 rats derived from la ×  BB and  lb x  BB crosses (9), although 
WF rats are serologically and MHC RFLP identical  to BB rats using both class 
I- and  II-specific reagents.  The  incidence of diabetes in  F2  rats derived from 
2al  or  2a2  BBN  X  BB crosses (when both  grandparents  carried  diabetogenic 
MHC genes) was three- to fivefold higher. Previously, it was impossible to directly 
test the diabetogenicity of the WF RTP because it is indistinguishable  from the 
BB RTP. With the availability of class I-defined 2a 1 and 2a2 diabetogenic MHC 
RFLPs, the diabetogenicity of the potentially nondiabetogenic  WF (2a0) MHC 
can now be directly assessed in breeding studies. 
The  availability  of  three  diabetogenic  MHC  types  should  be  of  value  in 
localizing and defining the diabetogenic MHC-linked gene in the rat. Because of 
its  similarities  to  the  MHC-linked  diabetogenic  gene  in  the  NOD  mouse and 
man, these studies may provide data with more general implications for the role 
of the MHC in DM and other autoimmune diseases. 
Summary 
Class I and II major histocompatibility complex (MHC) probes can be used to 
subdivide diabetes-prone BB rats and their BBN control strain,  coderived from 
the same outbred colony by selection against diabetes. Class II probes (A-alpha 
in  particular)  distinguish  four  restriction  fragment  length  polymorphisms 
(RFLP), termed  la,  lb, 2a, and 2b, in the BBN population,  only one of which 
(2a) is found in BB rats. The degree of class II RFLP in the population studied 
is  RT1.B-alpha  _  RT1.B-beta >  RT1.D-alpha  -  RT1.D-beta,  suggesting that 
intra-class  II region dynamics may be different in rats compared with mice. A 
class I probe (S 16) absolutely distinguished BB from BBN rats, since all BB rats 
exhibit an RFLP pattern termed 2a0, while 2a BBN rats can be subdivided into 456  DIABETOGEN1C  HISTOCOMPATIBILITY HAPLOTYPES  IN  BB  RATS 
2al  and  2a2 forms. Serologic evaluation  has shown that  2a0,  2al, and  2a2 rats 
express RT1 .A"B °,  la rats express RT1.AaD  a, and  lb rats express neither RTI" 
nor RTl ° at the  loci tested.  A  breeding study was carried out to determine  the 
diabetogenicity of the  MHC-defined  RFLP's.  As expected,  the  BB-derived  2a0 
is  diabetogenic.  The  BBN-derived  2al  and  2a2  RFLPs  are  also  diabetogenic, 
while  la and  lb rats do not  carry MHC-linked diabetogenic genes.  The  MHC- 
linked diabetes gene acts in a  functionally recessive manner,  since there is a  10- 
fold  higher  incidence  in  homozygotes  than  in  heterozygotes.  Analysis  of the 
RFLP patterns leads us to hypothesize that the 2al  RFLP results from a crossover 
between  la and  2a0  MHCs and  that  the  diabetogenic  MHC-linked  gene  is on 
the  class  II  side  of  Qa  and  Tl.  The  availability  of  three  diabetogenic  MHC 
haplotypes should help localize the MHC-linked diabetogenic gene of rats. 
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